Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.
Tung N, Ricker C, Messersmith H, Balmaña J, Domchek S, Stoffel EM, Almhanna K, Arun B, Chavarri-Guerra Y, Cohen SA, Cragun D, Crew KD, Hall MJ, Idos G, Lopez G, Pal T, Pirzadeh-Miller S, Pritchard C, Rana HQ, Swami U, Vidal GA. Tung N, et al. Among authors: rana hq. J Clin Oncol. 2024 Jul 20;42(21):2599-2615. doi: 10.1200/JCO.24.00662. Epub 2024 May 17. J Clin Oncol. 2024. PMID: 38759122
TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome.
Gray PN, Tsai P, Chen D, Wu S, Hoo J, Mu W, Li B, Vuong H, Lu HM, Batth N, Willett S, Uyeda L, Shah S, Gau CL, Umali M, Espenschied C, Janicek M, Brown S, Margileth D, Dobrea L, Wagman L, Rana H, Hall MJ, Ross T, Terdiman J, Cullinane C, Ries S, Totten E, Elliott AM. Gray PN, et al. Oncotarget. 2018 Apr 17;9(29):20304-20322. doi: 10.18632/oncotarget.24854. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755653 Free PMC article.
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
Rana HQ, Stopfer JE, Weitz M, Kipnis L, Koeller DR, Culver S, Mercado J, Gelman RS, Underhill-Blazey M, McGregor BA, Sweeney CJ, Petrucelli N, Kokenakes C, Pirzadeh-Miller S, Reys B, Frazier A, Knechtl A, Fateh S, Vatnick DR, Silver R, Kilbridge KE, Pomerantz MM, Wei XX, Choudhury AD, Sonpavde GP, Kozyreva O, Lathan C, Horton C, Dolinsky JS, Heath EI, Ross TS, Courtney KD, Garber JE, Taplin ME. Rana HQ, et al. JCO Oncol Pract. 2023 Nov;19(11):1069-1079. doi: 10.1200/OP.23.00007. Epub 2023 Sep 21. JCO Oncol Pract. 2023. PMID: 37733980 Free PMC article. Clinical Trial.
Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer.
Landry KK, DeSarno MJ, Kipnis L, Barquet Ramos F, Breen KM, Patton K, Morrissette A, Buehler RM, Ukaegbu C, Rohanizadegan M, Yurgelun MB, Syngal S, Rana HQ, Garber JE. Landry KK, et al. Among authors: rana hq. JCO Precis Oncol. 2024 Dec;8:e2400553. doi: 10.1200/PO-24-00553. Epub 2024 Dec 12. JCO Precis Oncol. 2024. PMID: 39666927
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S. Daly MB, et al. J Natl Compr Canc Netw. 2016 Feb;14(2):153-62. doi: 10.6004/jnccn.2016.0018. J Natl Compr Canc Netw. 2016. PMID: 26850485
An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes.
Schwartz A, Manning DK, Koeller DR, Chittenden A, Isidro RA, Hayes CP, Abraamyan F, Manam MD, Dwan M, Barletta JA, Sholl LM, Yurgelun MB, Rana HQ, Garber JE, Ghazani AA. Schwartz A, et al. Among authors: rana hq. Front Oncol. 2022 Aug 25;12:942741. doi: 10.3389/fonc.2022.942741. eCollection 2022. Front Oncol. 2022. PMID: 36091175 Free PMC article.
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
Berchuck JE, Boiarsky D, Silver R, Sunkara R, McClure HM, Tsai HK, Siegmund S, Tewari AK, Nowak JA, Lindeman NI, Rana HQ, Choudhury AD, Pomerantz MM, Freedman ML, Van Allen EM, Taplin ME. Berchuck JE, et al. Among authors: rana hq. JCO Precis Oncol. 2022 Aug;6:e2200329. doi: 10.1200/PO.22.00329. JCO Precis Oncol. 2022. PMID: 36103646 Free PMC article. Clinical Trial.
65 results